Methionine-35 of A β (1–42): Importance for Oxidative Stress in Alzheimer Disease

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · see citing works

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · see citing works

Oxidative stress hypothesis in Alzheimer’s disease

Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383 · see citing works

Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · see citing works

Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease

Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239 · see citing works

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide

Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114 · see citing works

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction

Huang, X., Atwood, C., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J. T., Moir, R. D., et al. (1999) · Biochemistry · doi:10.1021/bi990438f · Cited by 1,107 · see citing works

Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression

Manczak, M., Anekonda, T. S., Henson, E., Park, B. S., Quinn, J., & Reddy, P. H. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl066 · Cited by 1,104 · see citing works

Metals, oxidative stress and neurodegenerative disorders

Jomová, K., Vondráková, D., Lawson, M. K., & Valko, M. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0563-x · Cited by 1,053 · see citing works

Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress

Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 999 · see citing works

Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial

Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988 · see citing works

Biologically relevant metal ion‐dependent hydroxyl radical generation An update

Halliwell, B. B., & Gutteridge, J. M. C. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80911-y · Cited by 884 · see citing works

Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052146.x · Cited by 779 · cited 1× · see citing works

Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease

Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Lustbader, J. W., Xu, H. W., Stern, D., McKhann, G., & Du Yan, S. (2005) · The FASEB Journal · doi:10.1096/fj.05-3735fje · Cited by 738 · see citing works

Review: Alzheimer's Amyloid β-Peptide-Associated Free Radical Oxidative Stress and Neurotoxicity

Varadarajan, S., Yatin, S., Aksenova, M., & Butterfield, D. A. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4274 · Cited by 735 · see citing works

Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death1

Allanbutterfield, D., Castegna, A., Lauderback, C. M., & Drake, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715 · see citing works

Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity

Pike, C. J., Walencewicz‐Wasserman, A. J., Kosmoski, J., Cribbs, D. H., Glabe, C. G., & Cotman, C. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010253.x · Cited by 699 · see citing works

Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits

Curtain, C. C., Ali, F. E. A., Volitakis, I., Cherny, R. A., Norton, R. S., Beyreuther, K. T., Barrow, C. J., Masters, C. L., Bush, A. I., & Barnham, K. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100175200 · Cited by 653 · see citing works

The redox chemistry of the Alzheimer's disease amyloid β peptide

Smith, D. G., Cappai, R., & Barnham, K. J. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.002 · Cited by 608 · see citing works

Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases

Choi, J., Levey, A. I., Weintraub, S. T., Rees, H. D., Gearing, M., Chin, L.-S., & Li, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314124200 · Cited by 568 · see citing works

Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

Butterfield, D. A., Reed, T., Newman, S. F., & Sultana, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.037 · Cited by 564 · see citing works

Evidence of increased oxidative damage in subjects with mild cognitive impairment

Keller, J. N., Schmitt, F. A., Scheff, S. W., Ding, Q., Chen, Q., Butterfield, D. A., & Markesbery, W. R. (2005) · Neurology · doi:10.1212/01.wnl.0000156156.13641.ba · Cited by 539 · see citing works

Protein oxidation in the brain in Alzheimer's disease

Aksenov, M. Y., Aksenova, M. V., Butterfield, D. A., Geddes, J. W., & Markesbery, W. R. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00580-7 · Cited by 503 · see citing works

Relative Abundance of Alzheimer A Beta Amyloid Peptide Variants in Alzheimer Disease and normal Aging

Näslund, J., Schierhorn, A., Hellman, U., Lannfelt, L., Roses, A. D., Tjernberg, L. O., Silberring, J., Gandy, S. E., Winblad, B., & Greengard, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8378 · Cited by 468 · see citing works

The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464 · see citing works

Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro

Subbarao, K. V., Richardson, J. S., & Ang, L. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08858.x · Cited by 463 · see citing works

Methionine in proteins defends against oxidative stress

Luo, S., & Levine, R. L. (2008) · The FASEB Journal · doi:10.1096/fj.08-118414 · Cited by 462 · see citing works

β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease

Butterfield, D. A., Hensley, K., Harris‐White, M. E., Mattson, M. P., & Carney, J. M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1508 · Cited by 404 · see citing works

A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor

Lu, D. C.-T., Rabizadeh, S., Chandra, S. S., Shayya, R. F., Ellerby, L., Ye, X., Salvesen, G. S., Koo, E. H., & Bredesen, D. E. (2000) · Nature Medicine · doi:10.1038/74656 · Cited by 395 · see citing works

Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease

Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377 · see citing works

Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease

Schöneich, C. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.09.009 · Cited by 372 · see citing works

Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1–42) in a transgenic Caenorhabditis elegans model

Drake, J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00225-7 · Cited by 371 · see citing works

Different Mechanisms of Oxidative Stress and Neurotoxicity for Alzheimer‘s Aβ(1−42) and Aβ(25−35)

Varadarajan, S., Kanski, J., Aksenova, M., Lauderback, C., & Butterfield, D. A. (2001) · Journal of the American Chemical Society · doi:10.1021/ja010452r · Cited by 346 · see citing works

Oxidation of Methionine Residues of Proteins: Biological Consequences

Stadtman, E. R., Moskovitz, J., & Levine, R. L. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603770310239 · Cited by 344 · see citing works

Discussion

(1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00056-1 · Cited by 330 · see citing works

Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity

White, A. R., Du, T., Laughton, K. M., Volitakis, I., Sharples, R. A., Xilinas, M. E., Hoke, D. E., Holsinger, R. M. D., Evin, G., Cherny, R. A., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602487200 · Cited by 284 · see citing works

Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment

Markesbery, W. R., Kryscio, R. J., Lovell, M. A., & Morrow, J. D. (2005) · Annals of Neurology · doi:10.1002/ana.20629 · Cited by 272 · see citing works

The Lipid Peroxidation Product, 4‐Hydroxy‐2‐<i>trans</i>‐Nonenal, Alters the Conformation of Cortical Synaptosomal Membrane Proteins

Subramaniam, R., Roediger, F., Jordan, B., Mattson, M. P., Keller, J. N., Waeg, G., & Butterfield, D. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031161.x · Cited by 270 · see citing works

Drug Development Based on the Metals Hypothesis of Alzheimer's Disease

Bush, A. I. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15208 · Cited by 267 · see citing works

The critical role of methionine 35 in Alzheimer's amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicity

Butterfield, D. A., & Debra Boyd-kimball, A. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.014 · Cited by 267 · see citing works

Protein Oxidation and Lipid Peroxidation in Brain of Subjects with Alzheimer's Disease: Insights into Mechanism of Neurodegeneration from Redox Proteomics

Rukhsana Sultana, A., Marzia Perluigi, A., & Butterfield, D. A. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2021 · Cited by 261 · see citing works

Genome-wide association studies in Alzheimer’s disease

Bertram, L., & Tanzi, R. E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp406 · Cited by 257 · see citing works

Decrease in Peptide Methionine Sulfoxide Reductase in Alzheimer's Disease Brain

Gabbita, S. P., Aksenov, M. Y., Lovell, M. A., & Markesbery, W. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731660.x · Cited by 256 · see citing works

Effects of injected Alzheimer beta-amyloid cores in rat brain.

Frautschy, S. A., Baird, A., & Cole, G. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8362 · Cited by 254 · see citing works

Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment

Butterfield, D. A., Reed, T., Perluigi, M., De Marco, C., Coccia, R., Cini, C., & Sultana, R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.017 · Cited by 246 · see citing works

Vitamin E Prevents Alzheimer's Amyloid ß-Peptide (1-42)-Induced Neuronal Protein Oxidation and Reactive Oxygen Species Production

Yatin, S. M., Varadarajan, S., & Butterfield, D. A. (2000) · Journal of Alzheimer s Disease · doi:10.3233/jad-2000-2212 · Cited by 239 · see citing works

Reversal of Alzheimer’s-like pathology and behavior in human APP transgenic mice by mutation of Asp664

Galvan, V., Gorostiza, O. F., Banwait, S., Ataie, M., Logvinova, A. V., Sitaraman, S., Carlson, E., Sagi, S. A., Chevallier, N., Jin, K., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509695103 · Cited by 239 · see citing works

Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis

Sultana, R., Perluigi, M., & Butterfield, D. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0517-0 · Cited by 215 · see citing works

Oxidative Nerve Cell Death in Alzheimers Disease and Stroke: Antioxidants as Neuroprotective Compounds

Behl, C., & Moosmann, B. (2002) · Biological Chemistry · doi:10.1515/bc.2002.053 · Cited by 203 · see citing works

Free Radical Reactions of Methionine in Peptides: Mechanisms Relevant to β-Amyloid Oxidation and Alzheimer's Disease

Schöneich, C., Pogocki, D., Hug, G. L., & Bobrowski, K. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036733b · Cited by 199 · see citing works

In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid β-peptide of APP

Butterfield, D. A., Galván, V., Lange, M. L. B., Tang, H., Robinson, R. A. S., Spilman, P. R., Fombonne, J., Gorostiza, O. F., Zhang, J., Rukhsana Sultana, A., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.10.035 · Cited by 188 · see citing works

Neurotoxic, Redox-competent Alzheimer's β-Amyloid Is Released from Lipid Membrane by Methionine Oxidation

Barnham, K. J., Ciccotosto, G. D., Tickler, A. K., Ali, F. E. A., Smith, D. G., Williamson, N. A., Lam, Y.-H., Carrington, D., Tew, D. J., Kocak, G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305494200 · Cited by 188 · see citing works

Amyloid Accumulation and Pathogensis of Alzheimer’s Disease: Significance of Monomeric, Oligomeric and Fibrillar Aβ

Glabe, C. C. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_8 · Cited by 187 · see citing works

Biomarkers of oxidative stress are significantly elevated in Down syndrome

Jovanovic, S. V., Clements, D., & MacLeod, K. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00137-3 · Cited by 183 · see citing works

Redox proteomics: from protein modifications to cellular dysfunction and disease

Butterfield, D. A., & Dalle‐Donne, I. (2013) · Mass Spectrometry Reviews · doi:10.1002/mas.21404 · Cited by 180 · see citing works

The biochemistry of methionine sulfoxide residues in proteins

Brot, N., & Weissbach, H. (1982) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(82)90204-3 · Cited by 171 · see citing works

Neuronal Death and Survival Under Oxidative Stress in Alzheimer and Parkinson Diseases

Nunomura, A., Moreira, P. I., Lee, H., Zhu, X., Castellani, R. J., Smith, M. A., & Perry, G. L. (2007) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152707783399201 · Cited by 139 · see citing works

Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: Implications for Aβ accumulation in AD brain

Owen, J. B., Rukhsana Sultana, A., Aluise, C. D., Erickson, M. A., Price, T. O., Bu, G., Banks, W. A., & Butterfield, D. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.013 · Cited by 130 · see citing works

Oxidation of Methionine 35 Attenuates Formation of Amyloid β-Peptide 1–40 Oligomers

Palmblad, M., Westlind‐Danielsson, A., & Bergquist, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112218200 · Cited by 129 · see citing works

Amyloid β Protein: Aβ40 Inhibits Aβ42 Oligomerization

Murray, M. M., Bernstein, S. L., Nyugen, V., Condron, M. M., Teplow, D. B., & Bowers, M. T. (2009) · Journal of the American Chemical Society · doi:10.1021/ja8092604 · Cited by 128 · see citing works

Examination of the current top candidate genes for AD in a genome-wide association study

Feulner, T. M., Laws, S. M., Friedrich, P., Wagenpfeil, S., Wurst, S. H. R., Riehle, C., Kuhn, K. A., Krawczak, M., Schreiber, S., Nikolaus, S., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.141 · Cited by 128 · see citing works

Oxidative Damage to Proteins, Lipids, and DNA in Cortical Brain Regions from Patients with Dementia with Lewy Bodies

Lyras, L., Perry, R. H., Perry, E. K., Ince, P. G., Jenner, A. M., Jenner, P. G., & Halliwell, B. B. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010302.x · Cited by 121 · see citing works

SET protein (TAF1β, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain

Madeira, A., Pommet, J., Prochiantz, A., & Allinquant, B. (2005) · The FASEB Journal · doi:10.1096/fj.05-3839fje · Cited by 121 · see citing works

β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease

Wan, L., Nie, G., Zhang, J., Luo, Y., Zhang, P., Zhang, Z., & Zhao, B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.707 · Cited by 121 · see citing works

Trolox and 17β-Estradiol Protect against Amyloid β-Peptide Neurotoxicity by a Mechanism That Involves Modulation of the Wnt Signaling Pathway

Quintanilla, R. A., Muñoz, F. J., Metcalfe, M., Hitschfeld, M., Olivares, G. H., Godoy, J. A., & Inestrosa, N. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411936200 · Cited by 113 · see citing works

Amyloid β‐Peptides Increase Annular and Bulk Fluidity and Induce Lipid Peroxidation in Brain Synaptic Plasma Membranes

Avdulov, N. A., Chochina, S. V., Igbavboa, U., O‘Hare, E., Schroeder, F., Cleary, J. P., & Wood, W. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052086.x · Cited by 106 · see citing works

Alzheimer’s amyloid β-peptide (1–42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: An intriguing role for methionine 35

Clementi, M. E., Pezzotti, M., Orsini, F., Sampaolese, B., Mezzogori, D., Grassi, C., Giardina, B., & Misiti, F. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.137 · Cited by 105 · see citing works

Melatonin protects SHSY5Y neuroblastoma cells from cobalt‐induced oxidative stress, neurotoxicity and increased β‐amyloid secretion

Olivieri, G., Hess, C. W., Savaskan, E., Ly, C. V., Meier, F., Baysang, G., Brockhaus, M., & Müller-Spahn, F. (2001) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2001.310406.x · Cited by 105 · see citing works

Depletion of Vitamin E Increases Amyloid β Accumulation by Decreasing Its Clearances from Brain and Blood in a Mouse Model of Alzheimer Disease

Nishida, Y., Ito, S., Ohtsuki, S., Yamamoto, N., Takahashi, T., Iwata, N., Jishage, K.-I., Yamada, H., Sasaguri, H., Yokota, S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.054056 · Cited by 104 · see citing works

Enhanced Toxicity and Cellular Binding of a Modified Amyloid β Peptide with a Methionine to Valine Substitution

Ciccotosto, G. D., Tew, D. J., Curtain, C. C., Smith, D., Carrington, D., Masters, C. L., Bush, A. I., Cherny, R. A., Cappai, R., & Barnham, K. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406465200 · Cited by 101 · see citing works

Oxidatively modified RNA in mild cognitive impairment

Lovell, M. A., & Markesbery, W. R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.030 · Cited by 93 · see citing works

Alzheimer β protein mediated oxidative damage of mitochondrial DNA: Prevention by melatonin

Pappolla, M. A., Chyan, Y., Pöeggeler, B., Bozner, P., Ghiso, J. A., LeDoux, S. P., & Wilson, G. L. (1999) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1999.tb00619.x · Cited by 89 · see citing works

Enzymatic reactions involved in the repair of oxidized proteins

Mary, J., Vougier, S., Picot, C. R., Perichon, M., Petropoulos, I., & Friguet, B. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.06.008 · Cited by 87 · see citing works

Enhanced brain levels of 8,12- <i>iso</i> -iPF _2α -VI differentiate AD from frontotemporal dementia

Yao, Y., Zhukareva, V., Sung, S., Clark, C. M., Rokach, J., Lee, V. M.-Y., Trojanowski, J. Q., & Praticò, D. (2003) · Neurology · doi:10.1212/01.wnl.0000070185.02546.5d · Cited by 86 · see citing works

Role of glycine-33 and methionine-35 in Alzheimer’s amyloid β-peptide 1–42-associated oxidative stress and neurotoxicity

Kański, J., Varadarajan, S., Aksenova, M. V., & Butterfield, D. A. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00097-7 · Cited by 83 · see citing works

Development of a Method for Quantification of Acrolein−Deoxyguanosine Adducts in DNA Using Isotope Dilution-Capillary LC/MS/MS and Its Application to Human Brain Tissue

Liu, X., Lovell, M. A., & Lynn, B. C. (2005) · Analytical Chemistry · doi:10.1021/ac050624t · Cited by 79 · see citing works

Radioiodinated clioquinol as a biomarker for β‐amyloid: Zn2+ complexes in Alzheimer's disease

Opazo, C., Luza, S., Villemagne, V. L., Volitakis, I., Rowe, C. C., Barnham, K. J., Altschul, D., Masters, C. L., Cherny, R. A., & Bush, A. I. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00196.x · Cited by 76 · see citing works

Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Aβ(1–42)☆

Rukhsana Sultana, A., Marzia Perluigi, A., & Butterfield, D. A. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.09.024 · Cited by 72 · see citing works

Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.

Boyd-Kimball, D., Abdul, H. M., Reed, T. T., Sultana, R., & Butterfield, D. (2004) · Chemical Research in Toxicology · doi:10.1021/tx049796w · Cited by 67 · see citing works

Redox Properties of Met35in Neurotoxic β-Amyloid Peptide. A Molecular Modeling Study

Pogocki, D., & Schöneich, C. (2002) · Chemical Research in Toxicology · doi:10.1021/tx0101550 · Cited by 66 · see citing works

Chapter 9 Alzheimer's Disease Genetics

Bertram, L. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)00409-7 · Cited by 62 · see citing works

Cyclic oxidation and reduction of methionine residues of proteins in antioxidant defense and cellular regulation

Stadtman, E. R. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.10.001 · Cited by 61 · see citing works

The hydrophobic environment of Met35 of Alzheimer's Aβ(1–42) is important for the neurotoxic and oxidative properties of the peptide

Kański, J., Aksenova, M. V., & Butterfield, D. A. (2002) · Neurotoxicity Research · doi:10.1080/10298420290023945 · Cited by 58 · see citing works

Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation

Johansson, A., Bergquist, J., Volbracht, C., Päiviö, A., Leist, M., Lannfelt, L., & Westlind‐Danielsson, A. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3280b07c21 · Cited by 54 · see citing works

Despite its role in assembly, methionine 35 is not necessary for amyloid β‐protein toxicity

Maiti, P., Lomakin, A., Benedek, G. B., & Bitan, G. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06692.x · Cited by 46 · see citing works

Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide(1–42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function

Misiti, F., Clementi, M. E., & Giardina, B. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.01.002 · Cited by 44 · see citing works

Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664

Galván, V., Zhang, J., Gorostiza, O. F., Banwait, S., Huang, W., Ataie, M., Tang, H., & Bredesen, D. E. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.03.035 · Cited by 43 · see citing works

The N‐terminal copper‐binding domain of the amyloid precursor protein protects against Cu 2+ neurotoxicity in vivo

Cerpa, W. F., Barría, M. I., Chacón, M. A., Suazo, M., González, M., Opazo, C., Bush, A. I., & Inestrosa, N. C. (2004) · The FASEB Journal · doi:10.1096/fj.03-1349fje · Cited by 41 · see citing works

Possible involvement of copper(II) in Alzheimer disease.

Kowalik‐Jankowska, T., Ruta-Dolejsz, M., Wiśniewska, K., Łankiewicz, L., & Kozłowski, H. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s5869 · Cited by 38 · see citing works

Methionine 35 oxidation reduces toxic effects of the amyloid β-protein fragment (31–35) on human red blood cell

Clementi, M. E., Martorana, G. E., Pezzotti, M., Giardina, B., & Misiti, F. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.03.006 · Cited by 33 · see citing works

The radical model of Alzheimer's disease: Specific recognition of Gly29 and Gly33 by Met35 in a β-sheet model of Aβ: An ONIOM study

Brunelle, P., & Rauk, A. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4403 · Cited by 29 · see citing works

Mutation of the Phe20Residue in Alzheimer's Amyloid β-Peptide Might Decrease Its Toxicity Due to Disruption of the Met35−Cupric Site Electron Transfer Pathway

Pogocki, D. (2004) · Chemical Research in Toxicology · doi:10.1021/tx030044w · Cited by 18 · see citing works

Attenuated cytotoxicity but enhanced βfibril of a mutant amyloid β‐peptide with a methionine to cysteine substitution

Dai, X., Sun, Y., & Jiang, Z.-F. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.038 · Cited by 13 · see citing works

The oxidation of methionine-54 of epoetinum alfa does not affect molecular structure or stability, but does decrease biological activity.

LaBrenz, S. R., Calmann, M. A., Heavner, G. A., & Tolman, G. (2008) · PubMed · Cited by 13 · see citing works

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease

Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185 · see citing works

Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s disease

Jiang, T., Sun, Q., & Chen, S. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.07.005 · Cited by 594 · see citing works

Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease

Butterfield, D. A., & Boyd-Kimball, D. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170543 · Cited by 403 · see citing works

Implications of peptide assemblies in amyloid diseases

Ke, P. C., Sani, M., Ding, F., Käkinen, A., Javed, I., Separovic, F., Davis, T. P., & Mezzenga, R. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00372b · Cited by 338 · see citing works

Oxidative stress, protein modification and Alzheimer disease

Tramutola, A., Lanzillotta, C., Perluigi, M., & Butterfield, D. A. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.06.005 · Cited by 303 · see citing works

Importance of Iron Chelation in Free Radical-Induced Oxidative Stress and Human Disease

Jomová, K., & Valko, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072463 · Cited by 271 · see citing works

Protein damage, repair and proteolysis

Chondrogianni, N., Petropoulos, I., Grimm, S., Georgila, K., Catalgol, B., Friguet, B., Grune, T., & Gonos, E. S. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.09.001 · Cited by 254 · see citing works

Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease

Rajasekhar, K., Chakrabarti, M., & Govindaraju, T. (2015) · Chemical Communications · doi:10.1039/c5cc05264e · Cited by 241 · see citing works

Redox active metal-induced oxidative stress in biological systems

Jomová, K., Baroš, S., & Valko, M. (2012) · Transition Metal Chemistry · doi:10.1007/s11243-012-9583-6 · Cited by 244 · see citing works

Abeta, oxidative stress in Alzheimer disease: Evidence based on proteomics studies

Swomley, A. M., Förster, S., Keeney, J. T. R., Triplett, J. C., Zhang, Z., Rukhsana Sultana, A., & Butterfield, D. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.015 · Cited by 190 · see citing works

Oxidative Stress Occurs Prior to Amyloid Aβ Plaque Formation and Tau Phosphorylation in Alzheimer’s Disease: Role of Glutathione and Metal Ions

Roy, R. G., Mandal, P. K., & Maroon, J. C. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00486 · Cited by 194 · see citing works

3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases

Bandookwala, M., & Sengupta, P. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1713776 · Cited by 187 · see citing works

A <i>β</i> 42 and A <i>β</i> 40: similarities and differences

Qiu, T., Liu, Q., Chen, Y., Zhao, Y., & Li, Y. (2015) · Journal of Peptide Science · doi:10.1002/psc.2789 · Cited by 180 · see citing works

Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics

Swomley, A. M., & Butterfield, D. A. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1556-z · Cited by 171 · see citing works

Fine particulate matter induces mitochondrial dysfunction and oxidative stress in human SH-SY5Y cells

Wáng, Y., Zhang, M., Li, Z., Yue, J., Xu, M., Zhang, Y., Yung, K. K. L., & Li, R. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.11.149 · Cited by 149 · see citing works

Connecting the “Dots”: From Free Radical Lipid Autoxidation to Cell Pathology and Disease

Foret, M. K., Lincoln, R., Carmo, S. D., Cuello, A. C., & Cosa, G. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00761 · Cited by 144 · see citing works

Cognitive-enhancing and antioxidant activities of inhaled coriander volatile oil in amyloid β(1–42) rat model of Alzheimer's disease

Cioancă, O., Hriţcu, L., Mihăşan, M., & Hăncianu, M. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.08.006 · Cited by 129 · see citing works

The 2013 SFRBM Discovery Award: Selected discoveries from the Butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment

Butterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.006 · Cited by 126 · see citing works

Microspectroscopy (μFTIR) Reveals Co-localization of Lipid Oxidation and Amyloid Plaques in Human Alzheimer Disease Brains

Benseny‐Cases, N., Klementieva, O. L., Cotte, M., Ferrer, I., & Cladera, J. (2014) · Analytical Chemistry · doi:10.1021/ac502667b · Cited by 121 · see citing works

Opening Pandora‘s Jar: A Primer on the Putative Roles of Crmp2 In A Panoply of Neurodegenerative, Sensory and Motor Neuron, and Central Disorders

Khanna, R., Wilson, S. M., Brittain, J. M., Weimer, J. M., Rukhsana Sultana, A., Butterfield, D. A., & Hensley, K. (2012) · Future Neurology · doi:10.2217/fnl.12.68 · Cited by 112 · see citing works

Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases

Guerra‐Araiza, C., Álvarez-Mejía, L., Sánchez‐Torres, S., Farfán‐García, E. D., Mondragón‐Lozano, R., Pinto‐Almazán, R., & Salgado‐Ceballos, H. (2013) · Free Radical Research · doi:10.3109/10715762.2013.795649 · Cited by 109 · see citing works

The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease

Bedse, G., Romano, A., Lavecchia, A. M., Cassano, T., & Gaetani, S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141635 · Cited by 104 · see citing works

Photosensitizing materials and platforms for light-triggered modulation of Alzheimer's β-amyloid self-assembly

Lee, B. I., Chung, Y. J., & Park, C. B. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.043 · Cited by 96 · see citing works

Dietary Modulation of Oxidative Stress in Alzheimer’s Disease

Thapa, A., & Carroll, N. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071583 · Cited by 94 · see citing works

HIV Tat protein and amyloid-β peptide form multifibrillar structures that cause neurotoxicity

Hategan, A. P., Bianchet, M. A., Steiner, J. P., Karnaukhova, E., Masliah, E., Fields, A., Lee, M., Dickens, A. M., Haughey, N. J., Dimitriadis, E. K., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3379 · Cited by 93 · see citing works

Alzheimer’s disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior

Sharma, S., Verma, S., Kapoor, M., Saini, A., & Nehru, B. (2016) · Neurological Research · doi:10.1080/01616412.2016.1209337 · Cited by 89 · see citing works

Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions

Ren, F., Wei, J., Chen, Q., Hu, M., Yu, L., Mi, J., Zhou, X., Qin, D., Wu, J., & Wu, A. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.030 · Cited by 97 · see citing works

Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease

Giulia, N., Sestito, S., Digiacomo, M., & Rapposelli, S. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666170607114232 · Cited by 86 · see citing works

Oxidative Stress in Alzheimer's and Parkinson's Diseases: Insights from the YeastSaccharomyces cerevisiae

Pimentel, C., Batista-Nascimento, L. S., Rodrigues‐Pousada, C., & Menezes, R. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/132146 · Cited by 83 · see citing works

Inhalation of coriander volatile oil increased anxiolytic–antidepressant-like behaviors and decreased oxidative status in beta-amyloid (1–42) rat model of Alzheimer's disease

Cioancă, O., Hriţcu, L., Mihăşan, M., Trifan, A., & Hăncianu, M. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.04.021 · Cited by 84 · see citing works

Oxidative Modification of Brain Proteins in Alzheimer's Disease: Perspective on Future Studies Based on Results of Redox Proteomics Studies

Rukhsana Sultana, A., & Butterfield, D. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129018 · Cited by 83 · see citing works

An update on the interactions between Alzheimer's disease, autophagy and inflammation

Bostancıklıoğlu, M. (2019) · Gene · doi:10.1016/j.gene.2019.04.040 · Cited by 78 · see citing works

Acetyl-11-keto-β-boswellic acid ameliorates cognitive deficits and reduces amyloid-β levels in APPswe/PS1dE9 mice through antioxidant and anti-inflammatory pathways

Wei, C., Fan, J. J., Sun, X., Yao, J., Guo, Y., Zhou, B., & Shang, Y. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.022 · Cited by 72 · see citing works

Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease

Sultana, R., Baglioni, M., Cecchetti, R., Cai, J., Klein, J. B., Bastiani, P., Ruggiero, C., Mecocci, P., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.08.001 · Cited by 64 · see citing works

Novel tacrine–ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity

Mao, F., Chen, J., Zhou, Q., Luo, Z., Huang, L., & Li, X. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.034 · Cited by 62 · see citing works

Effects of different amyloid β-protein analogues on synaptic function

Ripoli, C., Piacentini, R., Riccardi, E., Leone, L., Puma, D. D. L., Bitan, G., & Grassi, C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.027 · Cited by 60 · see citing works

Redox proteomics and the dynamic molecular landscape of the aging brain

Marzia Perluigi, A., Swomley, A. M., & Butterfield, D. A. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.12.005 · Cited by 59 · see citing works

Effect of methionine-35 oxidation on the aggregation of amyloid-β peptide

Friedemann, M., Helk, E., Tiiman, A., Zovo, K., Palumaa, P., & Tõugu, V. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.07.017 · Cited by 53 · see citing works

From the dual function lead AP2238 to AP2469, a multi‐target‐directed ligand for the treatment of Alzheimer's disease

Tarozzi, A., Bartolini, M., Piazzi, L., Valgimigli, L., Amorati, R., Bolondi, C., Djemil, A., Mancini, F., Andrisano, V., & Rampa, A. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.23 · Cited by 49 · see citing works

The role of mitochondrial defects and oxidative stress in Alzheimer’s disease

Islam, B. U., Jabir, N. R., & Tabrez, S. S. M. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1584808 · Cited by 48 · see citing works

A Photolabile Curcumin‐Diazirine Analogue Enables Phototherapy with Physically and Molecularly Produced Light for Alzheimer's Disease Treatment**

Kuang, S., Zhu, B., Zhang, J., Yang, F., Wu, B., Ding, W., Yang, L., Shen, S., Liang, S. H., Mondal, P., et al. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202312519 · Cited by 44 · see citing works

Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer’s Disease

Chandran, S., & Binninger, D. (2023) · Antioxidants · doi:10.3390/antiox13010021 · Cited by 44 · see citing works

Discovery of Nobiletin from Citrus Peel as a Potent Inhibitor of β-Amyloid Peptide Toxicity

Youn, K., Lee, S., & Jun, M. (2019) · Nutrients · doi:10.3390/nu11112648 · Cited by 39 · see citing works

Simulations of monomeric amyloid β-peptide (1–40) with varying solution conditions and oxidation state of Met35: Implications for aggregation

Brown, A. M., Lemkul, J. A., Schaum, N., & Bevan, D. R. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.01.002 · Cited by 38 · see citing works

Oxidative Stress-mediated Lipid Peroxidation-derived Lipid Aldehydes in the Pathophysiology of Neurodegenerative Diseases

Allowitz, K. V., Taylor, J., Harames, K., Yoo, J., Baloch, O. A., & Ramana, K. V. (2024) · Current Neuropharmacology · doi:10.2174/011570159x342720241014164650 · Cited by 38 · see citing works

Studies of Polymorphism of Amyloid-β 42 Peptide from Different Suppliers

Suvorina, M. Y., Selivanova, O. M., Grigorashvili, E. I., Никулин, А. Д., Marchenkov, V. V., Surin, A. K., & Galzitskaya, O. V. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150147 · Cited by 36 · see citing works

Molecular evidences on anti‐inflammatory, anticancer, and memory‐boosting effects of frankincense

Khajehdehi, M., Khalaj‐Kondori, M., & Baradaran, B. (2022) · Phytotherapy Research · doi:10.1002/ptr.7399 · Cited by 37 · see citing works

The Role of Insulin Signaling in Hippocampal-Related Diseases: A Focus on Alzheimer’s Disease

Liu, Q., Wang, Z., Cao, J., Dong, Y., & Chen, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214417 · Cited by 37 · see citing works

Structural Insight into Redox Dynamics of Copper Bound N-Truncated Amyloid-β Peptides from in Situ X-ray Absorption Spectroscopy

Streltsov, V. A., Ekanayake, R. S. K., Drew, S. C., Chantler, C. T., & Best, S. P. (2018) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.8b01255 · Cited by 34 · see citing works

Heme Oxygenase-1 Activity as a Correlate to Exercise-Mediated Amelioration of Cognitive Decline and Neuropathological Alterations in an Aging Rat Model of Dementia

Kurucz, A., Bombicz, M., Kiss, R., Priksz, D., Varga, B., Hortobágyi, T., Trencsényi, G., Szabó, R., Pósa, A., Gesztelyi, R., et al. (2018) · BioMed Research International · doi:10.1155/2018/7212861 · Cited by 32 · see citing works

Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy

Maszka, P., Kwaśniak-Butowska, M., Cysewski, D., Sławek, J. W., Smolenski, R. T., & Tomczyk, M. (2023) · Metabolites · doi:10.3390/metabo13030369 · Cited by 30 · see citing works

Effects of Intrinsic and Extrinsic Factors on Aggregation of Physiologically Important Intrinsically Disordered Proteins

Breydo, L., Redington, J., & Uversky, V. N. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.08.011 · Cited by 29 · see citing works

The link between intraneuronal N-truncated amyloid-β peptide and oxidatively modified lipids in idiopathic autism and dup(15q11.2-q13)/autism

Frackowiak, J., Mazur‐Kolecka, B., Schanen, N. C., Brown, W. T., & Węgiel, J. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-61 · Cited by 29 · see citing works

Carbenoxolone Reverses the Amyloid Beta 1–42 Oligomer–Induced Oxidative Damage and Anxiety-Related Behavior in Rats

Sharma, S., Sharma, N., Saini, A., & Nehru, B. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9975-2 · Cited by 29 · see citing works

The Protein Oxidation Repair Enzyme Methionine Sulfoxide Reductase A Modulates Aβ Aggregation and Toxicity In Vivo

Minniti, A. N., Arrázola, M. S., Bravo‐Zehnder, M., Ramos, F., Inestrosa, N. C., & Aldunate, R. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5803 · Cited by 25 · see citing works

Spatio-temporal monitoring of lipid peroxyl radicals in live cell studies combining fluorogenic antioxidants and fluorescence microscopy methods

Greene, L. E., Lincoln, R., & Cosa, G. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.04.006 · Cited by 25 · see citing works

Synchrotron-Based Fourier Transform Infrared Microspectroscopy (μFTIR) Study on the Effect of Alzheimer’s Aβ Amorphous and Fibrillar Aggregates on PC12 Cells

Benseny‐Cases, N., Álvarez-Marimon, E., Castillo-Michel, H. A., Cotte, M., Falcon, C., & Cladera, J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04818 · Cited by 24 · see citing works

Probing and Trapping a Sensitive Conformation: Amyloid-β Fibrils, Oligomers, and Dimers

Fawver, J. N., Duong, K. T., Wise-Scira, O., Chapa, R. P., Schall, H. E., Coskuner‐Weber, O., Zhu, X., Colom, L. V., & Murray, I. V. J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120880 · Cited by 24 · see citing works

Component of Cannabis, Cannabidiol, as a Possible Drug against the Cytotoxicity of Aβ(31–35) and Aβ(25–35) Peptides: An Investigation by Molecular Dynamics and Well-Tempered Metadynamics Simulations

Chrobak, W., Pacut, D. W., Blomgren, F., Rodin, A., Swenson, J., & Ermilova, I. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00692 · Cited by 23 · see citing works

Timosaponin-BII inhibits the up-regulation of BACE1 induced by Ferric Chloride in rat retina

Huang, J.-F., Shang, L., Liu, P., Zhang, M.-Q., Chen, S., Chen, D., Fan, C.-L., Wang, H., & Xiong, K. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-189 · Cited by 21 · see citing works

Low Erythrocyte Levels of Proteasome and Acyl-Peptide Hydrolase (APEH) Activities in Alzheimer’s Disease: A Sign of Defective Proteostasis?

Palmieri, G., Cocca, E., Gogliettino, M., Valentino, R., Ruvo, M., Cristofano, G., Angiolillo, A., Balestrieri, M., Rossi, M., & Costanzo, A. D. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170389 · Cited by 21 · see citing works

Real-time evolution of Aβ40 metal-catalyzed oxidation reveals Asp1 as the main target and a dependence on metal binding site

Cheignon, C., Hureau, C., & Collin, F. (2017) · Inorganica Chimica Acta · doi:10.1016/j.ica.2017.07.031 · Cited by 21 · see citing works

Alzheimer’s Disease, Drosophila melanogaster and Polyphenols

Jiménez-Del-Río, M., & Velez‐Pardo, C. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-18365-7_2 · Cited by 20 · see citing works

Alzheimer Disease: The Role of Aβ in the Glutamatergic System

Campos‐Peña, V., & Antônio, M. (2014) · InTech eBooks · doi:10.5772/57367 · Cited by 18 · see citing works

Novel photocatalytic carbon dots: efficiently inhibiting amyloid aggregation and quickly disaggregating amyloid aggregates

Shao, X., Wang, C., Wang, C., Bai, M., Hou, T., Wang, X., Yan, C., Guan, P., & Hu, X. (2024) · Nanoscale · doi:10.1039/d3nr06165e · Cited by 17 · see citing works

Effect of an Intracerebroventricular Injection of Aggregated Beta-amyloid (1–42) on Daily Rhythms of Oxidative Stress Parameters in the Prefrontal Cortex

Ledezma, C., Coria-Lucero, C. D., Delsouc, M. B., Casais, M., Vedova, C. D., Ramírez, D. C., Devia, C. M., Delgado, S. M., Navigatore-Fonzo, L., & Anzulovich, A. C. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.08.016 · Cited by 16 · see citing works

Hydrogen Peroxide Modifies Aβ–Membrane Interactions with Implications for Aβ40 Aggregation

Pilkington, A. W., Donohoe, G. C., Akhmedov, N. G., Ferrebee, T., Valentine, S. J., & Legleiter, J. A. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00233 · Cited by 15 · see citing works

Application of carbon dots-based nanomaterials in amyloid aggregation disease

Yan, C., Shao, X., Wang, Y., Tang, S., Li, S., Wang, C., Bai, M., Qi, Y., Ma, Y., Zhao, R., et al. (2024) · Carbon · doi:10.1016/j.carbon.2024.119971 · Cited by 13 · see citing works

Photocatalytic, photothermal, and blood-brain barrier-permeable carbon nanodots: A potent multifunctional scavenger for β-amyloid plaque.

Shao, X., Li, M., Yan, C., Wang, C., Wang, X., Guan, P., Hu, X., & Fan, L. (2024) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2024.114380 · Cited by 14 · see citing works

Anti-Amyloidogenic Effects of Metasequoia glyptostroboides Fruits and Its Active Constituents

Yeo, J.-Y., Lee, S., Ko, M. S., Lee, C. H., Choi, J. Y., Hwang, K. W., & Park, S. (2023) · Molecules · doi:10.3390/molecules28031017 · Cited by 11 · see citing works

Molecular interactions of resveratrol with Aβ 42 peptide and fibril during in-vitro Aβ 42 aggregation

Sharma, S., Goyal, H., Joshi, S., Nehru, B., & Saini, A. (2023) · Advances in Redox Research · doi:10.1016/j.arres.2023.100060 · Cited by 11 · see citing works

Telomere length and oxidative stress variations in a murine model of Alzheimer’s disease progression

Martínez‐González, K., Islas‐Hernández, A., Martínez‐Ezquerro, J. D., Bermúdez‐Rattoni, F., & Garcia‐delaTorre, P. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14877 · Cited by 8 · see citing works

An intracerebroventricular injection of amyloid-beta peptide (1–42) aggregates modifies daily temporal organization of clock factors expression, protein carbonyls and antioxidant enzymes in the rat hippocampus

Navigatore-Fonzo, L., Alfaro, M., Mazaferro, P., Golini, R. S., Leporatti, J., Vedova, M. C. D., Ramírez, D. C., Delsouc, M. B., Casais, M., & Anzulovich, A. C. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147449 · Cited by 9 · see citing works

Neuroprotective activity of macroalgal fucofuroeckols against amyloid β peptide‐induced cell death and oxidative stress

Shrestha, S., Choi, J. S., Zhang, W. Y., & Smid, S. D. (2022) · International Journal of Food Science & Technology · doi:10.1111/ijfs.15753 · Cited by 8 · see citing works

Synthesis of novel 4-methylthiocoumarin and comparison with conventional coumarin derivative as a multi-target-directed ligand in Alzheimer’s disease

Kumar, S., Tyagi, Y. K., Kumar, S., & Kumar, S. (2020) · 3 Biotech · doi:10.1007/s13205-020-02481-1 · Cited by 8 · see citing works

Selective Oxidation of L-Methionine, L-Ethionine, N-Acetyl-L-Methionine, L-Buthionine Catalyzed by [FeIII-Salen]Cl Complexes: A Spectral, Kinetic, and Electrochemical Study

Karuppasamy, P. (2021) · Russian Journal of Physical Chemistry A · doi:10.1134/s0036024421150127 · Cited by 7 · see citing works

Ellagic acid improves the symptoms of early-onset Alzheimer's disease: Behavioral and physiological correlates

Jha, A., Chaube, U., & Jha, A. B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37372 · Cited by 7 · see citing works

Role of Oxidized Gly25, Gly29, and Gly33 Residues on the Interactions of Aβ1–42 with Lipid Membranes

Fatafta, H., Poojari, C., Sayyed–Ahmad, A., Strodel, B., & Owen, M. C. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00558 · Cited by 8 · see citing works

Intraneuronal accumulation of amyloid-β peptides as the pathomechanism linking autism and its co-morbidities: epilepsy and self-injurious behavior — the hypothesis

Frackowiak, J., & Mazur‐Kolecka, B. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1160967 · Cited by 7 · see citing works

Nanostructure and dynamics of N-truncated copper amyloid-β peptides from advanced X-ray absorption fine structure

Ekanayake, R. S. K., Streltsov, V. A., Best, S. P., & Chantler, C. T. (2024) · IUCrJ · doi:10.1107/s2052252524001830 · Cited by 6 · see citing works

Amyloid-β-Dependent Inactivation of the Mitochondrial Electron Transport Chain at Low Transmembrane Potential: An Ameliorating Process in Hypoxia-Associated Neurodegenerative Disease?

Pepperberg, D. R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190476 · Cited by 6 · see citing works

Assessment and Validation of Globodera pallida as a Novel In Vivo Model for Studying Alzheimer’s Disease

Althobaiti, N. A., Menaa, F., Albalawi, A. E., Dalzell, J. J., Warnock, N. D., Mccammick, E. M., Alsolais, A., Alkhaibari, A. M., & Green, B. D. (2021) · Cells · doi:10.3390/cells10092481 · Cited by 6 · see citing works

Nanoparticles for the potential treatment of Alzheimer’s disease: A physiopathological approach

Martínez, N. M. N., Toledo, J. A., & Morales, J. O. (2023) · Nanotechnology Reviews · doi:10.1515/ntrev-2022-0548 · Cited by 6 · see citing works

Unsaturated Fatty Acids Are Decreased in Aβ Plaques in Alzheimer's Disease

Röhr, D., Helfrich, M., Höring, M., Großerueschkamp, F., Liebisch, G., & Gerwert, K. B. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16306 · Cited by 5 · see citing works

A Photolabile Curcumin‐Diazirine Analogue Enables Phototherapy with Physically and Molecularly Produced Light for Alzheimer's Disease Treatment**

Kuang, S., Zhu, B., Zhang, J., Yang, F., Wu, B., Ding, W., Yang, L., Shen, S., Liang, S. H., Mondal, P., et al. (2023) · Angewandte Chemie · doi:10.1002/ange.202312519 · Cited by 5 · see citing works

Co‐treatment with the seed of Carthamus tinctorius L. and the aerial part of Taraxacum coreanum synergistically suppresses Aβ25–35‐induced neurotoxicity by altering APP processing

He, M. T., Kim, J. H., & Cho, E. J. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3768 · Cited by 4 · see citing works

Oxidative Stress in Neurodegenerative Diseases

Alami, M., Fülöp, T., Boumezough, K., Khalil, A., Zerif, E., & Berrougui, H. (2024) · Springer eBooks · doi:10.1007/978-3-031-69962-7_4 · Cited by 5 · see citing works

S100b protects IMR-32 cells against Ab(1-42) induced neurotoxicity via modulation of apoptotic genes expression

Clementi, M. E., Sampaolese, B., Triggiani, D., Tiezzi, A., & Giardina, B. (2013) · Advances in Alzheimer s Disease · doi:10.4236/aad.2013.23013 · Cited by 5 · see citing works

The Fate of Sulfur Radical Cation of N-Acetyl-Methionine: Deprotonation vs. Decarboxylation

Grzyb, K., Sehrawat, V., & Pędziński, T. (2023) · Photochem · doi:10.3390/photochem3010007 · Cited by 4 · see citing works

Globodera pallida, a non-transgenic invertebrate as a new model for investigating Alzheimer’s disease (and other proteinopathies)?

Althobaiti, N. A., Menaa, F., Green, B., & Dalzell, J. J. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.341042 · Cited by 4 · see citing works

Antioxidant activities of inula viscosa extract and curcumin on U87 cells induced by beta-amyloid

Alizade, A., & Özbolat, G. (2021) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.854213 · Cited by 3 · see citing works

Methionine 35 sulphoxide reduces toxicity of Aβ in red blood cell

Carelli‐Alinovi, C., & Misiti, F. (2017) · European Journal of Clinical Investigation · doi:10.1111/eci.12735 · Cited by 3 · see citing works

Body Fluid Biomarkers of Neurological Injury in HIV-1-Associated Neurocognitive Disorder

Mei-juan, Y., Zhang, X., Zhang, D., Zhang, Y., Wang, J., Zhang, Y., Gu, C., Zhang, X., & Wei, L. (2025) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2024.0053 · Cited by 2 · see citing works

A Comprehensive and Concise Review on Significance of Potent Peptide; Amyloid Beta (Aβ) in Progression of Alzheimer’s Disease

Aziz, N., Wal, P., Singh, Y. K., Kumar, P., & Singh, B. (2024) · Current Drug Therapy · doi:10.2174/0115748855299317241014051505 · Cited by 2 · see citing works

Molecular etiopathogenesis of neurodegenerative diseases

Divya, D., Thekkekkara, D., Sai, T. E., Ramakrishna, D., Manjula, S. N., & Goswami, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00002-7 · Cited by 2 · see citing works

Two statins and cromolyn as possible drugs against the cytotoxicity of Aβ(31–35) and Aβ(25–35) peptides: a comparative study by advanced computer simulation methods

Blomgren, F., Rodin, A., Chrobak, W., Pacut, D. W., Swenson, J., & Ermilova, I. (2022) · RSC Advances · doi:10.1039/d2ra01963a · Cited by 2 · see citing works

Stress oxydant et maladie d’Alzheimer

Gilbert, T., Drai, J., & Bonnefoy, M. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0443-9_10 · Cited by 2 · see citing works

PF-06447475 Molecule Attenuates the Neuropathology of Familial Alzheimer’s and Coexistent Parkinson’s Disease Markers in PSEN1 I416T Dopaminergic-like Neurons

Quintero-Espinosa, D. A., Velez‐Pardo, C., & Jiménez-Del-Río, M. (2025) · Molecules · doi:10.3390/molecules30092034 · Cited by 1 · see citing works

Insights into the Molecular Mechanism Underlying tBID-Triggered Cell Death Probed by In Situ Raman Spectroscopy

Li, S., Chen, Y., Li, W., Liao, Y., Zhu, J., Cai, L., & Han, X. (2025) · Nano Letters · doi:10.1021/acs.nanolett.5c04794 · Cited by 1 · see citing works

doi:10.4061/2011/198430 Review Article Methionine-35 of Aβ(1–42): Importance for Oxidative Stress in Alzheimer Disease

Butterfield, D. A., & Rukhsana Sultana, A. (2011)

Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer’s amyloid β-peptide 1–42

Butterfield, D. A., & Kański, J. (2002) · Peptides · doi:10.1016/s0196-9781(02)00066-9 · Cited by 151 · see citing works

The critical role of methionine 35 in Alzheimer's amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicity

Butterfield, D. A., & Debra Boyd-kimball, A. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.014 · Cited by 267 · see citing works

Review: methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer’s amyloid �-peptide 1–42. Peptides 2002;23:1299–309

Butterfield, D. A., & Kański, J. (2013)

Review The critical role of methionine 35 in Alzheimer’s amyloid h-peptide (1–42)-induced oxidative stress and neurotoxicity

Butterfield, D. A., & Debra Boyd-kimball, A. (2004)